wie hängen darm und blase zusammen — which blood markers matter?

The gut–bladder axis is an emerging concept. Evidence suggests that intestinal barrier dysfunction and dysbiosis can trigger systemic low-grade inflammation, which may affect the bladder – relevant to interstitial cystitis, recurrent UTIs, and overactive bladder. Blood markers discussed include hs-CRP, IL-6, zonulin (gut permeability), lipopolysaccharide-binding protein (LBP), and anti-flagellin or anti-LPS antibodies. However, clinical utility is limited. No single blood marker is validated for diagnosing or monitoring the gut–bladder connection. Most evidence comes from mechanistic studies or small cohorts. In practice, standard urological workup (urinalysis, cystoscopy, stool pathogen testing) remains essential. Dietary interventions (e.g., low-FODMAP, increased fiber) may help some patients, but blood markers alone should not guide treatment. Be cautious of consumer tests claiming to assess the gut–bladder axis via blood. Evidence grade: mechanistic/unclear – not yet human-strong.